Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (7) , 836-844
- https://doi.org/10.1038/labinvest.3700098
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosisGene Therapy, 2003
- Ameliorative Effect of Hepatocyte Growth Factor on Glycerol-Induced Acute Renal Failure with Acute Tubular NecrosisNephron, 2002
- Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic ratsGene Therapy, 2001
- Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGFJournal of Clinical Investigation, 2000
- Bleomycin-induced pulmonary fibrosis in fibrinogen-null miceJournal of Clinical Investigation, 2000
- Scatter factor/hepatocyte growth factor is essential for liver developmentNature, 1995
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factorPublished by Elsevier ,1991
- Molecular cloning and expression of human hepatocyte growth factorNature, 1989
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984